Princeton Global Asset Management LLC Citius Pharmaceuticals, Inc. Transaction History
Princeton Global Asset Management LLC
- $397 Million
- Q1 2024
A detailed history of Princeton Global Asset Management LLC transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Princeton Global Asset Management LLC holds 4,000 shares of CTXR stock, worth $2,720. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,000
Previous 4,000
-0.0%
Holding current value
$2,720
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CTXR
# of Institutions
73Shares Held
26.8MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY8.73MShares$5.93 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.01MShares$4.76 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.95MShares$2 Million0.0% of portfolio
-
State Street Corp Boston, MA2.21MShares$1.5 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL1.12MShares$761,7960.0% of portfolio
About Citius Pharmaceuticals, Inc.
- Ticker CTXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 146,130,000
- Market Cap $99.4M
- Description
- Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...